IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,626,397 | +30.9% | 1,173,686 | +55.6% | 0.44% | +42.0% |
| Q2 2023 | $14,234,603 | +17303.4% | 754,351 | +3441.6% | 0.31% | +15500.0% |
| Q1 2023 | $81,792 | -96.7% | 21,300 | -95.7% | 0.00% | -96.5% |
| Q4 2022 | $2,473,552 | -18.3% | 498,700 | -6.6% | 0.06% | -32.1% |
| Q3 2021 | $3,027,000 | +2487.2% | 534,000 | +2001.5% | 0.08% | +950.0% |
| Q2 2020 | $117,000 | +41.0% | 25,410 | +5.0% | 0.01% | +14.3% |
| Q1 2020 | $83,000 | +6.4% | 24,200 | -33.0% | 0.01% | 0.0% |
| Q2 2019 | $78,000 | -2.5% | 36,095 | +22.9% | 0.01% | -12.5% |
| Q1 2019 | $80,000 | – | 29,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |